INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹47 Cr | ₹114 Cr | ₹-430 Cr | ₹370 Cr | ₹16 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDEGENE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹114 Cr |
| Mar2023 | ₹-430 Cr |
| Mar2022 | ₹370 Cr |
| Mar2021 | ₹16 Cr |
How is Net Cash Inflow / Outflow of INDEGENE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | -59.14 | |
| Mar2024 | ₹114 Cr | Positive | |
| Mar2023 | ₹-430 Cr | Negative | |
| Mar2022 | ₹370 Cr | 2,174.92 | |
| Mar2021 | ₹16 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹12,868.9 Cr | 7.3% | 22.9% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 7.3% |
22.9% |
-12.5% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses